Skip to content
value.today

Redwood Bioscience Inc.

Total raised
$11 M
2 rounds on record
Latest round
$3 M
Jan 2014
First round on record
Apr 2013
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Redwood Bioscience Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2014$3 MNo. 2$2 to $10 million

Redwood Bioscience Inc.: Raise no. 2, Jan 2014

Investors in this round

1 investor had bought by the notice of Jan 28, 2014: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Gordon Rabuka · Executive Officer, Director
  • Karen M Boezi · Executive Officer, Director
  • Michael M Blank · Executive Officer
  • Barry M Littlejohns · Director
  • Edward Gordon Mccracken · Director
  • J Gordon Foulkes · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series B Preferred Stock and the underlying Common Stock issuable upon conversion thereof”

Signed by Michael Blank, Secretary. Source: SEC Form D, newest notice filed Jan 28, 2014. Read the notice at the SEC.

equitySEC
Apr 2013$9 MNo. 1$2 to $10 million

Redwood Bioscience Inc.: Raise no. 1, Apr 2013

Investors in this round

11 investors had bought by the notice of Apr 22, 2013: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $12 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Gordon Rabuka · Executive Officer, Director
  • Karen Boezi · Executive Officer, Director
  • Michael Blank · Executive Officer
  • Barry Littlejohns · Director
  • Edward Gordon Mccracken · Director
  • J Gordon Foulkes · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Common and Series A Preferred Stock (including stock issued upon conversion of promissory notes), Warrants to purchase capital stock, Convertible Promissory note and the underlying Series A and Common Stock issuable upon exercise and conversion thereof”

Signed by Michael Blank, Secretary. Source: SEC Form D, newest notice filed Apr 22, 2013. Read the notice at the SEC.

equity, debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Redwood Bioscience Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2014).

    SEC Form D · Jan 2014

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2014

That is all the official record says: Redwood Bioscience Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Redwood Bioscience Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 11 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Redwood Bioscience Inc.
NameRoleNamed in
David Gordon RabukaExecutive officerJan 2014
Karen M BoeziExecutive officerJan 2014
Michael M BlankExecutive officerJan 2014
Karen BoeziExecutive officerApr 2013
Michael BlankExecutive officerApr 2013
Barry M LittlejohnsDirectorJan 2014
David Gordon RabukaDirectorJan 2014
Edward Gordon MccrackenDirectorJan 2014
J Gordon FoulkesDirectorJan 2014
Karen M BoeziDirectorJan 2014
Barry LittlejohnsDirectorApr 2013
Karen BoeziDirectorApr 2013